To this end, the Justification for the Use of Statin in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial demonstrated that the treatment of healthy individuals with rosuvastatin based solely on elevated CRP led to a reduced incidence of both arterial and venous reinforcing the important association between CRP and thrombosis [102,103]. The gene discussed is CRP; the disease is deep vein thrombosis.